期刊
CHILDREN-BASEL
卷 8, 期 9, 页码 -出版社
MDPI
DOI: 10.3390/children8090739
关键词
child; classification; central nervous system (CNS) tumor; diffuse intrinsic pontine glioma (DIPG); glioma; glioblastoma; high grade glioma; low grade glioma; mitogen-activated protein kinase (MAPK); targeted therapy
类别
The overall survival of pediatric gliomas varies depending on tumor grade, with low-grade tumors having better long-term survival and high-grade tumors having poor outcomes. Recent advancements in understanding the molecular background of pediatric gliomas are shaping the classification and treatment approaches, with molecularly targeted treatments potentially becoming a key component in managing these tumors, particularly in cases of high-grade gliomas.
The overall survival of pediatric gliomas varies over a wide spectrum depending on the tumor grade. Low-grade gliomas have an excellent long-term survival, with a possible burden of surgery, irradiation, and chemotherapy; in contrast, high-grade gliomas generally have a short-term, devastating lethal outcome. Recent advances in understanding their molecular background will transform the classification and therapeutic approaches of pediatric gliomas. Molecularly targeted treatments may acquire a leading role in the primary treatment of low-grade gliomas and may provide alternative therapeutic strategies for high-grade glioma cases in the attempt to avoid the highly unsuccessful conventional therapeutic approaches. This review aims to overview this progress.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据